Emsam
NDC Package 39506-044-30
Package Information
Emsam is selegiline is an antidepressant (monoamine oxidase inhibitor) that treats depression by restoring the balance of certain natural substances (neurotransmitters) in the brain. Marketed by Somerset Pharmaceuticals Inc., this product is identified by NDC 39506-044 and is authorized under FDA application NDA021336.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 39506 - Somerset Pharmaceuticals Inc.
- 39506-044 - Emsam
- 39506-044-30 - 30 POUCH in 1 BOX / 1 PATCH in 1 POUCH / 24 h in 1 PATCH
- 39506-044 - Emsam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 39506-044-30 identifies a specific commercial package of 30 pouch in 1 box / 1 patch in 1 pouch / 24 h in 1 patch of Emsam, labeled by Somerset Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Somerset Pharmaceuticals Inc. on December 13, 2010. The current certification is valid through December 31, 2010.
What are the primary indications for this medication?
Selegiline is an antidepressant (monoamine oxidase inhibitor) that treats depression by restoring the balance of certain natural substances (neurotransmitters) in the brain. Selegiline can improve your mood and feelings of well-being. This medication is a patch for use on the skin.
How is this Somerset Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 39506004430. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.